首页> 美国卫生研究院文献>Human Brain Mapping >Four in vivo g‐ratio‐weighted imaging methods: Comparability and repeatability at the group level
【2h】

Four in vivo g‐ratio‐weighted imaging methods: Comparability and repeatability at the group level

机译:四种体内g比例加权成像方法:组水平的可比性和可重复性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A recent method, denoted in vivo ‐ratio‐weighted imaging, has related the microscopic ‐ratio, only accessible by ex vivo histology, to noninvasive MRI markers for the fiber volume fraction (FVF) and myelin volume fraction (MVF). Different MRI markers have been proposed for ‐ratio weighted imaging, leaving open the question which combination of imaging markers is optimal. To address this question, the repeatability and comparability of four ‐ratio methods based on different combinations of, respectively, two imaging markers for FVF (tract‐fiber density, TFD, and neurite orientation dispersion and density imaging, NODDI) and two imaging markers for MVF (magnetization transfer saturation rate, MT, and, from proton density maps, macromolecular tissue volume, MTV) were tested in a scan–rescan experiment in two groups. Moreover, it was tested how the repeatability and comparability were affected by two key processing steps, namely the masking of unreliable voxels (e.g., due to partial volume effects) at the group level and the calibration value used to link MRI markers to MVF (and FVF). Our data showed that repeatability and comparability depend largely on the marker for the FVF (NODDI outperformed TFD), and that they were improved by masking. Overall, the ‐ratio method based on NODDI and MT showed the highest repeatability (90%) and lowest variability between groups (3.5%). Finally, our results indicate that the calibration procedure is crucial, for example, calibration to a lower ‐ratio value (  = 0.6) than the commonly used one (  = 0.7) can change not only repeatability and comparability but also the reported dependency on the FVF imaging marker. . ©
机译:最近的一种方法,称为体内比例加权成像,已将显微比例与纤维体积分数(FVF)和髓磷脂体积分数(MVF)的非侵入性MRI标记联系起来,而只有通过离体组织学才能达到这一比例。对于比例加权成像,已经提出了不同的MRI标记,这留下了哪种成像标记组合是最佳的问题。为了解决这个问题,分别基于两种FVF成像标记(束纤维密度,TFD和神经突取向弥散和密度成像,NODDI)和两种成像标记的四种比率方法的可重复性和可比性在两组的扫描-再扫描实验中测试了MVF(磁化传递饱和率MT,以及质子密度图上的大分子组织体积MTV)。此外,还测试了两个关键处理步骤如何影响可重复性和可比性,即在组级别屏蔽不可靠的体素(例如,由于部分体积效应)和用于将MRI标记与MVF连接的校准值(和FVF)。我们的数据表明,可重复性和可比性在很大程度上取决于FVF(NODDI优于TFD)的标记,并且通过掩膜可以改善它们。总体而言,基于NODDI和MT的比率方法显示出最高的可重复性(90%)和最低的组间差异(3.5%)。最后,我们的结果表明,校准程序至关重要,例如,校准到比常用值(one = 0.7)低的比率值(= 0.6)不仅会改变可重复性和可比性,而且还会改变所报告的对FVF的依赖性成像标记。 。 ©

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号